Attovia Therapeutics, Inc. (ATTO) stock
ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.10−0.48 (-3.08%)
Close on Nov 20, 2026Market cap $689.33MP/E –Yield –
Attovia Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | – |
| Q2 FY2026 | Jun 30, 2026 | $450.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $360.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
See a number that looks wrong?